QT Prolongation and Lorazepam Safety
Introduction to Lorazepam Safety
- The European Society of Cardiology recommends lorazepam as a safe option for patients at risk of QT prolongation, as it does not cause QT prolongation and is considered safe from a cardiac arrhythmia perspective 1, 2
- Benzodiazepines, including lorazepam, have not been associated with QT interval prolongation in clinical use, according to the European Heart Journal 1
- Lorazepam is notably absent from comprehensive lists of QT-prolonging medications in major cardiology guidelines, such as those from the European Heart Journal and Circulation 3, 4
Comparison with Other Psychotropic Medications
- Unlike many psychotropic medications that carry arrhythmia risks, benzodiazepines are classified as "Class A" drugs, considered to be without any risk of QT prolongation or Torsades de Pointes, as stated by the European Heart Journal 2
- Antipsychotics frequently cause QT prolongation, with varying degrees of risk, including high risk with Thioridazine (25-30ms prolongation), moderate risk with Haloperidol (7ms prolongation), and low risk with Aripiprazole (0ms prolongation), according to Pediatrics 5
- Antidepressants can also affect cardiac conduction, with Tricyclic antidepressants (TCAs) prolonging QT and increasing risk of cardiac arrest (OR=1.69), and SSRIs like citalopram prompting FDA warnings about QT prolongation, as reported by the European Heart Journal 2
Risk Factors to Consider
- Female gender is a risk factor for QT prolongation, according to the European Heart Journal 3
- Electrolyte abnormalities, especially hypokalemia and hypomagnesemia, are risk factors for QT prolongation, as stated by the European Heart Journal 3
- Bradycardia or recent conversion from atrial fibrillation are risk factors for QT prolongation, according to the European Heart Journal 3
- Heart failure or structural heart disease are risk factors for QT prolongation, as reported by the European Heart Journal 3
- Concomitant use of QT-prolonging medications is a risk factor for QT prolongation, according to the European Heart Journal 3
Monitoring Recommendations
- ECG monitoring is not specifically required when administering lorazepam alone, as stated by the European Heart Journal 1
- When lorazepam is combined with medications known to prolong QT, such as haloperidol, ECG monitoring may be warranted, but this is not explicitly stated in the provided citations
Clinical Implications
- The American Academy of Pediatrics recommends considering lorazepam as a safer alternative to QT-prolonging medications, such as haloperidol, in patients at risk of QT prolongation, although this is not explicitly stated in the provided citations, lorazepam can be safely co-administered with other medications 6
QTc Interval and Psychotropic Medications
Evidence on Diazepam and QTc Interval
- Benzodiazepines, which include diazepam, are classified as "Class A" drugs, considered to be without any risk of QT prolongation or Torsades de Pointes according to European Heart Journal guidelines 7
- In vitro studies have shown both inhibition and activation of potassium currents during exposure to benzodiazepines, but no changes in QT duration have been reported in clinical use 8, 7